Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms, Plasma Cell 2Multiple Myeloma 2cyclopia sequence 1Tobacco Use Cessation 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Nocturia 1Myelodysplastic Syndromes 1Lymphoma 1Lung Neoplasms 1Leukemia 1Hodgkin Disease 1Health Education 1Head and Neck Neoplasms 1Fatigue 1Dyspnea 1Carcinoma, Non-Small-Cell Lung 1Bronchiolitis Obliterans Syndrome 1Breast Neoplasms 1Advanced Cancers 1

Interventions

ibrutinib 2fludarabine 2Sirolimus 2Rituximab 2Mycophenolic Acid 2Cyclophosphamide 2oblimersen 1Whole-Body Irradiation 1Surveys and Questionnaires 1Mesna 1KW-2478 1Hsp90 inhibitor KU757 1Filgrastim 1Busulfan 1Bortezomib 1Acupuncture Therapy 14-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Bronchiolitis Obliterans Syndrome × Surveys and Questionnaires × Clear all
NCT01815346 2018-01-12

Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG

M.D. Anderson Cancer Center

Phase 1/2 Terminated
4 enrolled
Breast

Bronchiolitis Obliterans Syndrome, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡